- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antiparasitic
- Antibiotics
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Veterinary Medicines
- Quit Smoking
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
Generic Rhinocort ( Budesonide )
Rhinocort (budesonide) is an intranasal corticosteroid available without a prescription for the prevention and treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and non-allergic vasomotor rhinitis. It works by inhibiting the release of inflammatory mediators, reducing eosinophil infiltration, and suppressing the late-phase allergic reaction in the nasal mucosa. This potent anti-inflammatory action effectively relieves symptoms including nasal congestion, sneezing, runny nose, and itchy nose.
Usual adult dose: 2 sprays of Rhinocort 100 mcg nasal spray into each nostril once daily (total daily dose of 400 mcg). For maintenance therapy once symptom control is achieved, the dose may be reduced to 1 spray into each nostril once daily (total daily dose of 200 mcg). If once-daily dosing is insufficient, the 200 mcg daily dose may be divided into 1 spray per nostril twice daily. The lowest effective dose should be used for maintenance. For seasonal allergies, starting treatment 2 weeks prior to the expected onset of symptoms is recommended. Full therapeutic benefit may not be achieved until 1 to 2 weeks of continuous use; regular daily dosing is essential for optimal efficacy.
Dosage form: Nasal spray, aqueous suspension 100 mcg per metered spray. Each actuation delivers 100 mcg of micronized budesonide in a pH-adjusted isotonic suspension. Available in a 100-metered-spray amber glass bottle with a manual pump actuator.
Onset of action: Some symptom relief may begin within 10 hours of the first dose; however, significant clinical improvement is typically observed within 2 to 3 days. Maximum therapeutic benefit for seasonal allergic rhinitis is generally reached after approximately 1 to 2 weeks of consistent daily use. Budesonide is not intended for immediate or as-needed relief of acute nasal symptoms.
Duration of action: The local anti-inflammatory effect persists for approximately 24 hours following intranasal administration, supporting once-daily maintenance dosing. The systemic elimination half-life of budesonide is 2 to 3 hours; however, intranasal activity is determined by tissue residence time rather than plasma kinetics.
Alcohol recommendation: No clinically significant interaction exists between intranasal budesonide and alcohol. Alcohol consumption does not alter the efficacy or safety profile of Rhinocort. Patients may consume alcohol in moderation in accordance with general health guidelines, although alcohol may independently contribute to nasal congestion in susceptible individuals.
Most common side effects: Nasal irritation, epistaxis (nosebleed), pharyngitis, sneezing, coughing, and dryness of the nasal mucosa. Local nasal effects are generally mild and transient. The occurrence of epistaxis may be minimized by aiming the spray slightly away from the nasal septum during administration. Systemic corticosteroid effects are rare at recommended intranasal doses due to low systemic bioavailability.
Would you like to try Rhinocort (Budesonide) for lasting allergy symptom relief?
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
